Over 50 deaths linked to ‘unknown disease’ in Congo
A general view of the World Health Organization (WHO) on April 28, 2009, in Geneva, Switzerland. (Harold Cunningham/Getty Images)
(DEMOCRATIC REPUBLIC OF CONGO) — The World Health Organization has reported that there is a deadly “unknown disease” spreading in one region within the Democratic Republic of Congo.
Local health officials in Congo are partnering with the World Health Organization to investigate.
The phrase “unknown disease” primarily means that the disease has not yet been identified.
In previous cases, the cases are linked to a known disease, but a lack of available testing leads to lack of certainty.
For example, there was a separate report of an “unknown disease” in December of last year in Congo that was later attributed to illnesses from malaria and respiratory illnesses.
The latest numbers from the WHO’s Africa Region show that there are 431 cases linked to the outbreak and 53 deaths since January.
Early investigations traced the outbreak’s origin to three kids, all under 5 years old, who developed symptoms after eating a bat carcass.
Symptoms included fever, headache, diarrhea and fatigue – which later progressed to signs associated with hemorrhagic fevers and death.
Ebola and Marburg have already been ruled out, officials say. Nearly half of deaths occurred within 48 hours after symptoms start.
“The remote location and weak healthcare infrastructure increase the risk of further spread,” the WHO notes in its report.
(NEW YORK) — The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity — the first medication approved for the condition.
The new, expanded Zepbound approval means that insurance providers, including Medicare, will likely cover the medication for people with sleep apnea and obesity. Some insurance providers, including Medicare, do not offer reimbursement to treat obesity alone.
The new approval is for people with moderate to severe obstructive sleep apnea who are also living with obesity. Eli Lilly estimates that is about 15-20 million adults in the U.S.
Obstructive sleep apnea isn’t just an inconvenience, it’s a serious medical condition that impairs breathing and sleep quality. Obesity and obstructive sleep apnea are linked. People tend to see their obstructive sleep apnea get better when they lose a significant amount of weight. It’s likely the weight loss associated with the medication is helping improve the sleep apnea.
Right now, there is no medicine to treat obstructive sleep apnea — it’s only treated with a positive airway pressure device.
In a study, people who took Zepbound had at least 25 fewer breathing interruptions per hour while they slept. They also lost an average of 20% of their body weight.
The study also followed people over a year, and found that up to half of the adults taking Zepbound no longer had obstructive sleep apnea symptoms at the end of the year.
Obstructive sleep apnea is more common in men than women. Up to 34% of U.S. men have OSA compared to 17% of U.S. women, according to the American Academy of Family Physicians.
Common signs of sleep apnea include heavy snoring at night, long pauses in breathing while sleeping as well as excessive daytime sleepiness, forgetfulness and morning headaches. The symptoms of the disorder can lead to significant medical problems.
In this undated stock photo, signage for the Center for Disease Control and Prevention is shown. (STOCK PHOTO/Adobe Stock)
(WASHINGTON) — Medical groups are expressing deep concern about the sudden removal or alteration of government data sets and webpages from agencies like the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) at the behest of President Donald Trump’s administration.
The American Cancer Society, a non-profit organization dedicated to eliminating the disease, called on the administration to “restore access to comprehensive data, refrain from changes that would lead to incomplete future data collection and commit to ensure evidence-based science can proceed without additional bureaucracy or red tape” in a statement published on its website on Thursday.
“Any restriction to gather and release these data could thwart our ability to address and reduce the cancer burden across all communities,” interim CEO Dr. Wayne A. I. Frederick said in the statement.
The organization highlighted the removal of the Social Vulnerability Index, which uses U.S. census data to identify county-level risk and vulnerability factors facing communities, taking into account poverty, race, disability, housing and more, according to the CDC.
“Data from public sources like the Social Vulnerability Index are key to deploying the right resources to those who could benefit the most,” the group said. “Therefore, any barriers to accessing these data can also have repercussions on planning and deployment of support services for cancer patients and survivors.”
The Trump administration transition team didn’t immediately respond to ABC News’ request for comment.
Across the federal government, webpages and datasets were removed or altered following Trump’s executive orders on diversity, equity and inclusion (DEI) and transgender identities called for an “end” to any related policies within the federal government.
Webpages about HIV, LGBTQ+ people and multiple other public health topics were taken down. Some of the terms being flagged for removal include pregnant people, chestfeeding, diversity, DEI and references to vaccines, health and gender equity, according to officials at the Centers for Disease Control and Prevention who spoke to ABC News on the condition of anonymity.
Several data tools were also removed or modified, according to Frederick.
Frederick said data collected by a plethora of federal and state agencies play a key role in many of the organization’s reports and publications, including the agency’s “Cancer Statistics, 2025” report and its companion, the “Cancer Facts and Figures” report.
The organization’s reports provide up-to-date trends on cancer occurrence, survival, symptoms, prevention, early detection and treatment, Frederick said.
“ACS develops guidelines for cancer screening and prevention, informed by the latest available data and evidence, to meet the needs of clinicians, the general public, and policy,” he said. “We are very concerned that the changes in data collection and dissemination have the potential to impact these efforts in the future.”
The organization is concerned about how the scope and impact of data removal and potential long-term changes to data collection will impact its research capabilities.
The ACS warning came just days after the medical nonprofit group Doctors For America filed a lawsuit against several Trump administration agencies over its sudden removal of health information from multiple government websites.
The suit targets the Office of Personnel Management and the Department of Health and Human Services (which controls the CDC and FDA), asking a federal court in Washington, D.C. to order the government to restore the webpages and datasets.
ABC News has reached out to the agencies for comment.
In a statement to ABC News, the CDC confirmed that changes “to the HHS website and HHS division websites are in accordance with President Trump’s January 20 Executive Orders, Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government and Ending Radical And Wasteful Government DEI Programs And Preferencing.”
The Office of Personnel Management provided guidance on both executive orders, prompting HHS and divisions to respond accordingly, the spokesperson stated.
In a separate emailed statement to ABC News, the CDC’s SVI coordinator also attributed the online restrictions to the HHS “pause on mass communications and public appearances that are not directly related to emergencies or critical to preserving health.”
It said the pause will be brief, “to allow the new team to set up a process for review and prioritization.”
In the lawsuit, Doctors for America expressed concerns that the lack of data “creates a dangerous gap in the scientific data available to monitor and respond to disease outbreaks, deprives physicians of resources that guide clinical practice, and takes away key resources for communicating and engaging with patients.”
Asked last Friday afternoon if government websites would be shut down to be scrubbed, the president said it wouldn’t be a “bad idea.”
“DEI … would have ruined our country, and now it’s dead. I think DEI is dead,” Trump said. “So, if they want to scrub the website, that’s OK with me. But I can’t tell you.”
ABC News’ Youri Benadjaoud and Peter Charalambous contributed to this report.
(NEW YORK) — Flu activity remains “elevated” in the United States but is starting to show signs of abating, according to new federal data published Friday.
The 2024-25 flu season was classified by the Centers for Disease Control and Prevention (CDC) as a “high” severity season overall and for all age groups, making it the first high severity season since 2017-2018.
During the week ending Feb. 15, 6.8% of visits to doctors’ offices were for flu-like illness, down from 7.7% of visits over the previous two weeks, CDC data shows.
Emergency department visits for flu also fell to 6.4% during the week ending Feb. 15 from more than 8% for the two weeks prior.
Additionally, 26.9% of tests came back positive for flu during the week ending Feb. 15. This is higher than the peak of 18.2% last flu season but lower than the 31.4% recorded over the previous two weeks.
The CDC estimates there have been at least 33 million illnesses, 430,000 hospitalizations and 19,000 deaths from flu so far this season
At least 86 pediatric flu deaths have been recorded so far, with 18 reported the week ending Feb. 15.
It comes as overall respiratory illness activity is listed as “high” nationwide, CDC data shows.
As of Friday, nine states are listed as having “very high” levels of respiratory virus activity and 14 states are listed as “high.” The remaining states are listed as having “moderate” or “low” levels.
Comparatively, 12 states were listed as “very high” and 20 states were listed as “high” last week.
Meanwhile, although COVID-19 activity is “elevated” in many areas of the U.S., CDC data shows emergency department visits are at low levels and the number of laboratory tests coming back positive is stable.
Respiratory syncytial virus activity was also described as “elevated” but declining in most areas of the U.S., according to the CDC.
Public health experts have recommended children and adults receive the flu and COVID vaccine as well as older adults receive the RSV vaccine, but coverage is “low,” according to the CDC.
As of Feb 8, only 45.3% of adults were vaccinated against the flu and 23,1% were vaccinated with the updated 2024-25 COVID-19 vaccine. Additionally, just 46.7% of adults ages 75 and older have received the RSV vaccine, according to CDC data.
Nearly half of all children are vaccinated against the flu at 45.8%, but just 12.1% have received the updated COVID-19 vaccine.
